Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab plus Paclitaxel in Advanced Gastric Cancer
NCT05535569Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Jul 2017
- Primary completion
- Nov 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab in gastric adenocarcinoma, sponsored by Yonsei University. Started Jul 2017; status: completed.
02
Drugs
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT05535569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05535569.